UPDATE 2-EU gives final approval for GSK's RSV vaccine
Yahoo! Finance
The European Commission has approved GSK's respiratory syncytial virus (RSV) vaccine for older adults, the drugmaker said on Wednesday, making it the first shot in the region against the common respiratory disease that can be fatal for seniors. The move is the final step to allowing the vaccine's use across the European Union, after the European Medicines Agency (EMA) recommended it for approval in April.
Continue Reading